Diamonds and Dogs


Micron (MU) is up 3% ahead of earnings this Thursday thanks to two upgrades. Wells Fargo upgraded Micron with a $40 price target. Cowen upgraded the stock with a $38 price target. Its seems pretty certain the company will beat earnings estimates and probably raises estimates. The question is how much of the good news has been priced in?

Seattle Genetics (SGEN) is getting hit down 11% back to the lows of the year on disappointing stage three drug trial results. The drug did met the main goal in a late-stage study of helping blood cancer patients live longer without their condition worsening, but unfortunately the results provided little difference from the current drugs on the market.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.